Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07023666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 30, 2026 → Jun 30, 2027
See other at-risk trials from Inova Health Care Services

Record History

  1. Primary completion pushed from Jun 30, 2026 to Jun 30, 2027
    • Study completion pushed from Jun 30, 2027 to Dec 30, 2027
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Start date changed from estimate of Sep 30, 2025 to Oct 7, 2025
    v3
  3. Start date: Jun 30, 2025 to Sep 30, 2025v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study tests whether early heart screening and treatment for iron overload in subjects with sickle cell disease can prevent heart problems and reduce hospitalizations.
Trial Details
NCT Number NCT07023666
Lead Sponsor Inova Health Care Services
Conditions
(from sponsor)		 Sickle Cell Disease
Related terms Anemia, Sickle Cell, Arrhythmias, Cardiac, Cardiomyopathies, Iron Overload
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov